InvestorsHub Logo
Followers 21
Posts 1353
Boards Moderated 0
Alias Born 10/28/2011

Re: ggwpq post# 16647

Sunday, 10/13/2013 12:35:49 AM

Sunday, October 13, 2013 12:35:49 AM

Post# of 424548
Next question is? is the Chiba study admissible on 1016 as supporting evidence to expand label to combo VC with statin? guess they could say yes pending reduce it study. Mat be amrn has other doc
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News